Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson's in an international setting.

Bowring F. et al, (2022), BMJ Open, 12

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Poggiolini I. et al, (2022), Brain, 145, 584 - 595

Dietary Patterns and Nonmotor Symptoms in Parkinson's Disease: A Cross-Sectional Analysis.

Lawrie S. et al, (2022), J Am Nutr Assoc, 1 - 10

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease.

Lo C. et al, (2022), J Neurol Neurosurg Psychiatry

Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations.

Vignando M. et al, (2022), Nat Commun, 13

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder.

Sosero YL. et al, (2021), J Parkinsons Dis

Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.

Liu Y. et al, (2021), Mov Disord

Quantifying activities of daily living impairment in Parkinson's disease using the Functional Activities Questionnaire.

Becker S. et al, (2021), Neurol Sci

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.

Vijiaratnam N. et al, (2021), BMJ Open, 11

Validation of α-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes

TOFARIS G., (2021), Movement Disorders

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.

Mestre TA. et al, (2021), J Parkinsons Dis

Olfactory Testing in Parkinson's Disease & REM Behavior Disorder: A Machine Learning Approach.

Lo C. et al, (2021), Neurology

Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.

Arnaldi D. et al, (2021), Brain, 144, 278 - 287

Proof of concept: Screening for REM sleep behaviour disorder with a minimal set of sensors.

Cooray N. et al, (2021), Clin Neurophysiol, 132, 904 - 913

Temporal orienting in Parkinson’s disease

Zokaei N. et al, (2021), European Journal of Neuroscience

Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS.

Thompson AG. et al, (2021), Front Neurosci, 15

Smartphone Speech Testing for Symptom Assessment in Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

Arora S. et al, (2021), IEEE Access

Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder.

Mufti K. et al, (2020), Mov Disord

Dopamine promotes instrumental motivation, but reduces reward-related vigour

Grogan JP. et al, (2020), eLife, 9

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease

Norwitz NG. et al, (2020), Frontiers in Neuroscience, 14

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?